INCYTE CORP
INCY
64 insider filings · Latest: Aug 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Aug 14 8:01 PM | Pablo J CagnoniPresident, Global Head of R&D | Sale | 10,803 | $120.04 | $1.3M | 194,001(D) | View → |
| Aug 12, 2026 | Aug 12 8:09 PM | PABLO CAGNONI | Proposed Sale | 10,803 | $120.04 | $1.3M | — | View → |
| Aug 5, 2026 | Aug 7 8:02 PM | Pablo J CagnoniPresident, Global Head of R&D | Sale | 10,640 | $122.69 | $1.3M | 204,804(D) | View → |
| Aug 5, 2026 | Aug 7 8:01 PM | Patrick A MayesEVP & Chief Scientific Officer | Sale | 2,207 | $123.99 | $273.6K | 61,441(D) | View → |
| Aug 5, 2026 | Aug 5 8:15 PM | PABLO CAGNONI | Proposed Sale | 10,640 | $122.69 | $1.3M | — | View → |
| Aug 5, 2026 | Aug 5 8:14 PM | PATRICK A MAYES | Proposed Sale | 2,207 | $123.99 | $273.6K | — | View → |
| Jul 31, 2026 | Aug 4 8:04 PM | Pablo J CagnoniPresident, Global Head of R&D | Sale | 15,888 | $119.70 | $1.9M | 215,444(D) | View → |
| Aug 3, 2026 | Aug 4 8:04 PM | Patrick A MayesEVP & Chief Scientific Officer | Sale | 6,055 | $120.43 | $729.2K | 61,441(D) | View → |
| Jul 31, 2026 | Aug 4 8:04 PM | Patrick A MayesEVP & Chief Scientific Officer | Sale | 41,899 | $119.46 | $5.0M | 61,441(D) | View → |
| Aug 3, 2026 | Aug 3 8:39 PM | PATRICK A MAYES | Proposed Sale | 6,055 | $120.43 | $729.2K | — | View → |
| Jul 31, 2026 | Jul 31 8:59 PM | PATRICK A MAYES | Proposed Sale | 41,899 | $119.46 | $5.0M | — | View → |
| Jul 31, 2026 | Jul 31 8:04 PM | PABLO CAGNONI | Proposed Sale | 15,888 | $119.70 | $1.9M | — | View → |
| Jul 16, 2026 | Jul 20 8:10 PM | Steven H SteinCMO & Head of Late-Stage Dev. | Sale | 1,877 | $114.73 | $215.3K | 21,118(D) | View → |
| Jul 16, 2026 | Jul 20 8:09 PM | Mohamed Khairie IssaEVP, Head of U.S. Commercial | Sale | 1,093 | $115.01 | $125.7K | 63,940(D) | View → |
| Jul 16, 2026 | Jul 16 8:15 PM | STEVEN STEIN | Proposed Sale | 1,877 | $114.73 | $215.3K | — | View → |
| Jul 15, 2026 | Jul 16 8:07 PM | Steven H SteinCMO & Head of Late-Stage Dev. | Sale | 28,237 | $113.05 | $3.2M | 26,083(D) | View → |
| Jul 16, 2026 | Jul 16 8:04 PM | MOHAMED ISSA | Proposed Sale | 1,093 | $115.01 | $125.7K | — | View → |
| Jul 15, 2026 | Jul 15 8:09 PM | STEVEN STEIN | Proposed Sale | 28,237 | $113.05 | $3.2M | — | View → |
| Jun 4, 2026 | Jun 8 8:04 PM | Thomas TrayPrincipal Accounting Officer | Sale | 2,639 | $100.00 | $263.9K | 21,132(D) | View → |
| Jun 4, 2026 | Jun 4 8:03 PM | THOMAS R TRAY | Proposed Sale | 2,639 | $100.00 | $263.9K | — | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jun 10 8:05 PM | Otis W BrawleyDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 4, 2026 | Jun 8 8:04 PM | Thomas TrayPrincipal Accounting Officer | Option Exercise | 2,639 | $83.83 | 0(D) | View → |
| May 26, 2026 | May 28 8:03 PM | Jean Jacques BienaimeDirector | Option Exercise | 15,000 | $84.53 | 0(D) | View → |
| May 19, 2026 | May 21 8:02 PM | Paul J ClancyDirector | Option Exercise | 15,000 | $84.53 | 0(D) | View → |
| May 8, 2026 | May 11 8:45 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Option Exercise | 30,000 | $84.53 | 0(I) | View → |
| May 4, 2026 | May 6 8:34 PM | Suketu UpadhyayEVP & Chief Financial Officer | Grant/Award | 51,600 | $97.14 | 26,342(D) | View → |
| Apr 17, 2026 | Apr 21 8:09 PM | Pablo J CagnoniPresident, Global Head of R&D | Option Exercise | 18,667 | $71.93 | 27,699(D) | View → |
| Mar 17, 2026 | Mar 19 8:20 PM | Pablo J CagnoniPresident, R&D | Option Exercise | 18,667 | $64.25 | 32,910(D) | View → |
| Feb 19, 2026 | Feb 23 9:05 PM | Pablo J CagnoniPresident, R&D | Option Exercise | 18,668 | $61.76 | 16,268(D) | View → |
| Jan 16, 2026 | Jan 21 9:06 PM | Pablo J CagnoniPresident, R&D | Grant/Award | 28,475 | $106.21 | 28,475(D) | View → |
| Jan 16, 2026 | Jan 21 9:06 PM | Steven H SteinEVP & Chief Medical Officer | Grant/Award | 19,932 | $106.21 | 19,932(D) | View → |
| Jan 16, 2026 | Jan 21 9:06 PM | Mohamed Khairie IssaEVP, Head of US Oncology | Grant/Award | 14,237 | $106.21 | 14,237(D) | View → |
| Jan 16, 2026 | Jan 21 9:05 PM | Matteo TrottaEVP, GM, Dermatology US | Grant/Award | 8,542 | $106.21 | 8,542(D) | View → |
| Jan 16, 2026 | Jan 21 9:04 PM | Thomas TrayPrincipal Accounting Officer | Grant/Award | 2,425 | $106.21 | 2,425(D) | View → |
| Jan 16, 2026 | Jan 21 9:04 PM | Patrick A MayesEVP & Chief Scientific Officer | Grant/Award | 4,218 | $106.21 | 4,218(D) | View → |
← Previous
Page 2 of 2